Nephrology Doctors in Lake Mary, FL Accepting Medicare

5 Nephrology doctors found. Showing 1 - 5

Dr. Clarylee Octaviani, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 766 N Sun Dr Ste 3030, Lake Mary, FL 32746 Phone: 407-444-2800    Fax: 407-444-2810

Ivan Dario Maya, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 766 N Sun Dr, Suite 3030, Lake Mary, FL 32746 Phone: 407-444-2800

Vincent Disilvestro, Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 525 Technology Park Ste 109, Lake Mary, FL 32746 Phone: 407-644-2346    Fax: 847-506-1917

Jose L Santini, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 766 N Sun Dr, Suite 3030, Lake Mary, FL 32746 Phone: 407-444-2800    Fax: 407-444-2810

Alfred Rodriguez, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 766 N Sun Dr, Suite 3030, Lake Mary, FL 32746 Phone: 407-444-2800    Fax: 407-444-2810

News Archive

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus-associated pulmonary disease.

CRISPR tool unlocks potential for novel treatments across different therapeutic areas

CRISPR is one of the most exciting advances in gene-based medicine in decades. A uniquely powerful tool for editing the genome, it allows scientists to manipulate DNA with unprecedented precision by deleting unwanted or faulty genes and replacing them with different ones. Its promise in this field of medicine is immense, unlocking the potential for novel treatments across a wide range of therapeutic areas.

FDA approves CSL Behring's sBLA to extend shelf life of Hizentra from 18 to 24 months

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.

Promising new way to thwart tricky Mtb pathogen

Tuberculosis, an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective.

Read more Medical News

› Verified 9 days ago